Paliperidone
Invega, Paliperidone Janssen, Paliperidone Janssen-Cilag International, Trevicta, Xeplion (paliperidone) is a small molecule pharmaceutical. Paliperidone was first approved as Invega on 2006-12-19. It is used to treat bipolar disorder, depressive disorder, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. It has been approved in Europe to treat psychotic disorders and schizophrenia.
Trade Name | Invega, Paliperidone Janssen, Paliperidone Janssen-Cilag International, Trevicta, Xeplion |
---|---|
Common Name | Paliperidone |
Indication | bipolar disorder, depressive disorder, psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders |
Drug Class | Antipsychotics (risperidone type) |